(Q36887008)

16 August 2017

Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration (English)

1 reference

16 August 2017

Bucher HC

1

1 reference

16 August 2017

Weinbacher M

series ordinal

2

1 reference

16 August 2017

Gyr K

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 September 1994

1 reference

16 August 2017

1 reference

16 August 2017

309

1 reference

16 August 2017

761-764

1 reference

16 August 2017

6957

1 reference

Cholesterol lowering and mortality: the importance of considering initial level of risk

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2541000

Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2541000

Pharmaceutical prescriptions in four European countries

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2541000

An assessment of clinically useful measures of the consequences of treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2541000

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2541000

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2541000

Should there be a moratorium on the use of cholesterol lowering drugs?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2541000

Absolutely relative: how research results are summarized can affect treatment decisions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2541000

The problem with cholesterol

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2541000

Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7950558

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.309.6957.761

1 reference

16 August 2017

1 reference

16 August 2017

1 reference